Anvisa to reevaluate Thiram fungicide in Brazil

The National Health Surveillance Agency (Anvisa) has decided to reevaluate several toxicological aspects of the Thiram fungicide in Brazil. According to the agency, the goal is “to avoid wrong assumptions on the evaluation of this active ingredient, which could represent risk to human health and population.”

According to the agency, the decision was taken after the analysis of the contributions received during the Public Consultation (CP No. 128, January 29, 2016). The information from the regulators of Canada and the European Union, which recently published public consultations over the dangers and risks of Thiram, were also taken into consideration.

According to Anvisa, the reevaluation of this active ingredient will resume in 2017, after other reevaluations, during the Coordination of the Reevaluation of General Toxicology Managing.

The initial reevaluation was determined in February 22, 2008, but according to the opinion issued in 2015, Thiram “did not fit into the banned characteristics of registration in the Brazilian legislation, which resulted in the proposal for reevaluating the effects of Thiram in Brazil.”